<DOC>
	<DOCNO>NCT01479829</DOCNO>
	<brief_summary>This project attempt enhance augment antidepressant efficacy commonly use antidepressant poorly respond bipolar depress patient .</brief_summary>
	<brief_title>Bipolar Depression Inflammation</brief_title>
	<detailed_description>This placebo-controlled study patient bipolar I disorder ( BPD ) utilize well-known antidepressant , escitalopram ( ESC ) , combination anti-inflammatory agent , celecoxib ( CBX ) . The investigator hypothesize combination treatment lead qualitatively quantitatively augment response result great number remitters compare ESC monotherapy .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Ages 21 65 year old time screen visit . Both gender race accept . Diagnosis BPD I II without significant comorbid secondary medical psychiatric diagnosis ; substance abuse dependence precede 12 month A minimum score 18 first 17 item 21item Hamilton Depression Scale Willingness washout reasonable time ( depend substance ) : Vitamin E fish oil ( &gt; 600 IU/day ) , nonaspirin NSAIDs aspirin ( &gt; 81 mg/day , H2 receptor antagonist , Ginko biloba , caffeine morning blood drawing , institute lightsout 23:00 hour night blood drawing Any abnormal finding physical exam , ECG , blood/urine minor infection Any preexist physical pain condition , include fibromyalgia History peptic ulcer complicate perforation , hemorrhage , obstruction ; symptom peptic ulcer within 4 week enrollment date Any substance abuse dependence precede 12 month Clinically significant hypertension , anemia , liver disease , kidney disease , arthritis , diabetes , recurrent migraine , epilepsy , stroke , gum disease , autoimmune disease Current use lithium Current use stimulant Certain steroid include use hormonal birth control systemic topical corticosteroid ( hormone replacement therapy allow ) Unwillingness refrain H2 receptor antagonist , nonaspirin NSAIDs , aspirin ( mor 1 mg/day ) . Use anticoagulant agent Use nicotinecontaining substance . Subjects quit smoke 3 month prior assessment may consider study Known sensitivity allergy study medication need receive agent contraindicate combination CBX ESC Unwillingness fast abstain caffeine morning blood drawing A sleep disorder insomnia hypersomnia distinct symptom MDD Inability commit followup visit 8 11</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bipolar depression</keyword>
	<keyword>Celecoxib</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Inflammation</keyword>
</DOC>